TransMedics Group, Inc.

TMDXReported to SECin USCIK 0001756262Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 8. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 8
Form 4 lines at TransMedics Group, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Weill David—Open-market buy$109,0581,336 sharesSep 14, 2026Weill David$109,058Buy · Sep 14Open-market buy1,336Sep 14, 2026
TOBIN JAMES R—Giftnothing paid18,000 sharesAug 17, 2026TOBIN JAMES Rnothing paidGift · Aug 17Gift18,000Aug 17, 2026
Corcoran NicholasSee remarksAwardnothing paid17,784 sharesJul 14, 2026Corcoran NicholasSee remarksnothing paidAward · Jul 14Award17,784Jul 14, 2026
Corcoran NicholasSee remarksAwardnothing paid11,727 sharesJul 14, 2026Corcoran NicholasSee remarksnothing paidAward · Jul 14Award11,727Jul 14, 2026
Hernandez GerardoChief Financial OfficerAwardnothing paid26,153 sharesJul 14, 2026Hernandez GerardoChief Financial Officernothing paidAward · Jul 14Award26,153Jul 14, 2026